Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar - CNBC

Oct 30, 2025 - 08:00
 0  1
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar - CNBC
  1. Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar  CNBC
  2. Eli Lilly Stock Rises on Earnings and Boost to Guidance  Barron's
  3. Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance  Yahoo Finance
  4. Lilly Raises Guidance on Strength of Weight Loss, Obesity Drugs  Bloomberg
  5. Eli Lilly stock pops on raised full-year outlook (LLY:NYSE)  Seeking Alpha

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0